235 related articles for article (PubMed ID: 25414027)
1. Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis.
Dowsett M; Folkerd E
Breast Cancer Res Treat; 2015 Jan; 149(1):1-4. PubMed ID: 25414027
[TBL] [Abstract][Full Text] [Related]
2. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.
Labrie F
J Steroid Biochem Mol Biol; 2015 Jan; 145():133-8. PubMed ID: 24923731
[TBL] [Abstract][Full Text] [Related]
3. Interaction between menopausal status and obesity in affecting breast cancer risk.
Rose DP; Vona-Davis L
Maturitas; 2010 May; 66(1):33-8. PubMed ID: 20181446
[TBL] [Abstract][Full Text] [Related]
4. Relationship of obesity to blood estrogens.
Zumoff B
Cancer Res; 1982 Aug; 42(8 Suppl):3289s-3294s. PubMed ID: 7083189
[TBL] [Abstract][Full Text] [Related]
5. The role of ovarian sex steroids in metabolic homeostasis, obesity, and postmenopausal breast cancer: molecular mechanisms and therapeutic implications.
Boonyaratanakornkit V; Pateetin P
Biomed Res Int; 2015; 2015():140196. PubMed ID: 25866757
[TBL] [Abstract][Full Text] [Related]
6. Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer.
Wang X; Simpson ER; Brown KA
J Steroid Biochem Mol Biol; 2015 Sep; 153():35-44. PubMed ID: 26209254
[TBL] [Abstract][Full Text] [Related]
7. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers associated with breast cancer are associated with obesity.
Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
[TBL] [Abstract][Full Text] [Related]
9. Obesity, estrogen production, and tumor estrogen receptors in women with carcinoma of the breast.
Donegan WL; Johnstone MF; Biedrzycki L
Am J Clin Oncol; 1983 Feb; 6(1):19-24. PubMed ID: 6837504
[TBL] [Abstract][Full Text] [Related]
10. Sex hormones and breast cancer risk and prognosis.
Folkerd E; Dowsett M
Breast; 2013 Aug; 22 Suppl 2():S38-43. PubMed ID: 24074790
[TBL] [Abstract][Full Text] [Related]
11. Aromatase in aging women.
Bulun SE; Zeitoun K; Sasano H; Simpson ER
Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
[TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
J BUON; 2013; 18(2):335-41. PubMed ID: 23818343
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-metabolizing enzymes in breast cancers from women over the age of 80 years.
Honma N; Takubo K; Sawabe M; Arai T; Akiyama F; Sakamoto G; Utsumi T; Yoshimura N; Harada N
J Clin Endocrinol Metab; 2006 Feb; 91(2):607-13. PubMed ID: 16303840
[TBL] [Abstract][Full Text] [Related]
14. Obesity-associated Breast Cancer: Analysis of risk factors.
Engin A
Adv Exp Med Biol; 2017; 960():571-606. PubMed ID: 28585217
[TBL] [Abstract][Full Text] [Related]
15. In situ estrogen production and its regulation in human breast carcinoma: from endocrinology to intracrinology.
Sasano H; Miki Y; Nagasaki S; Suzuki T
Pathol Int; 2009 Nov; 59(11):777-89. PubMed ID: 19883428
[TBL] [Abstract][Full Text] [Related]
16. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
17. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
[TBL] [Abstract][Full Text] [Related]
18. Associations of Breast Cancer Risk Factors with Premenopausal Sex Hormones in Women with Very Low Breast Cancer Risk.
Houghton LC; Ganmaa D; Rosenberg PS; Davaalkham D; Stanczyk FZ; Hoover RN; Troisi R
Int J Environ Res Public Health; 2016 Oct; 13(11):. PubMed ID: 27809264
[TBL] [Abstract][Full Text] [Related]
19. Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.
Saez S; Martin PM; Chouvet CD
Cancer Res; 1978 Oct; 38(10):3468-73. PubMed ID: 688231
[TBL] [Abstract][Full Text] [Related]
20. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
Murphy MJ
Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
